Targeting the vector of arboviruses Aedes aegypti with nanoemulsions based on essential oils: a review with focus on larvicidal and repellent properties

• Laryssa Ferreira do Nascimento Silva,
• Douglas Dourado,
• Thayse Silva Medeiros,
• Mariana Alice Gonzaga Gabú,
• Maria Cecilia Queiroga dos Santos,
• Daiane Rodrigues dos Santos,
• Mylena Lemos dos Santos,
• Gabriel Bezerra Faierstein,
• Rosângela Maria Rodrigues Barbosa and
• Fabio Rocha Formiga

Beilstein J. Nanotechnol. 2025, 16, 1894–1913, doi:10.3762/bjnano.16.132

• nanoemulsions are discussed. In addition, this review highlights challenges and perspectives on pharmaceutical nanotechnology towards nanoemulsions as safe, effective, and eco-friendly tools for controlling Ae. Aegypti. Keywords: Aedes aegypti; arboviruses; mosquito vector; nanoemulsion; nanotechnology

• , pharmaceutical nanotechnology strategies such as nanoemulsions have been used as tools for vector control [79]. Numerous studies have shown that nanoemulsions can increase the solubility and prolong the larvicidal and/or repellent activity of essential oils, making them a promising solution to improve the

• efficacy of herbal products for mosquito control [80][81]. Nanoemulsions: Concepts and applications in larvicides and repellents Pharmaceutical nanotechnology offers innovative solutions for the delivery and targeting of molecules for therapeutic, prophylactic, or diagnostic purposes [82]. In 1995, the

Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension

• Khosro Adibkia,
• Ali Ehsani,
• Asma Jodaei,
• Ezzatollah Fathi,
• Raheleh Farahzadi and
• Mohammad Barzegar-Jalali

Beilstein J. Nanotechnol. 2021, 12, 786–797, doi:10.3762/bjnano.12.62

• Khosro Adibkia Ali Ehsani Asma Jodaei Ezzatollah Fathi Raheleh Farahzadi Mohammad Barzegar-Jalali Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran Department of Pharmaceutical Sciences, Faculty of Pharmacy, Tabriz University of Medical Sciences

Frontiers in pharmaceutical nanotechnology

• Matthias G. Wacker

Beilstein J. Nanotechnol. 2019, 10, 2538–2540, doi:10.3762/bjnano.10.244

• Matthias G. Wacker National University of Singapore, Faculty of Science, Department of Pharmacy, 6 Science Drive 2, 117546 Singapore 10.3762/bjnano.10.244 Keywords: drug delivery; nanocarriers; nanomedicines; nanotheranostics; pharmaceutical nanotechnology; Today, pharmaceutical nanotechnology

• materials with a long history of medical use [12]. Pharmaceutical nanotechnology is not limited to translational research but, after many years of trial and error, we have to accept that reliable pharmacological and toxicological effects are a key element of industrial formulation development. Understanding

BergaCare SmartLipids: commercial lipophilic active concentrates for improved performance of dermal products

• Florence Olechowski,
• Rainer H. Müller and
• Sung Min Pyo

Beilstein J. Nanotechnol. 2019, 10, 2152–2162, doi:10.3762/bjnano.10.208

• Florence Olechowski Rainer H. Muller Sung Min Pyo Berg + Schmidt GmbH & Co. KG, An der Alster 81, 20099 Hamburg, Germany Freie Universität Berlin, Institute of Pharmacy, Pharmaceutics, Pharmaceutical Nanotechnology & NutriCosmetics, Kelchstr. 31, Berlin 12169, Germany 10.3762/bjnano.10.208